Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
Kroon J, Puhr M, Buijs JT, van der Horst G, Hemmer DM, Marijt KA, Hwang MS, Masood M, Grimm S, Storm G, Metselaar JM, Meijer OC, Culig Z, van der Pluijm G.
Kroon J, et al. Among authors: hemmer dm.
Endocr Relat Cancer. 2016 Jan;23(1):35-45. doi: 10.1530/ERC-15-0343. Epub 2015 Oct 19.
Endocr Relat Cancer. 2016.
PMID: 26483423
Free PMC article.